WU-04 is a non-covalent inhibitor of SARS-CoV-2 targeting the 3CLpro protein; it exhibits potent inhibitory activity against the 3CLpro proteins of six SARS-CoV-2 variants (Alpha, Beta, Gamma, Delta, Lambda, and Omicron) and two other coronaviruses (SARS-CoV and MERS-CoV).